Long-term impact of the decrease of infliximab trough levels on the disease course in Inflammatory Bowel Disease patients under maintenance treatment with infliximab

被引：0
|
作者：
Orfanoudaki, E. [1 ]
Gazouli, M. [2 ]
Foteinogiannopoulou, K. [1 ]
Theodoraki, E. [1 ]
Legaki, E. [2 ]
Koutroubakis, I. [1 ]
机构：
[1] Univ Hosp Heraklion, Gastroenterol, Iraklion, Crete, Greece
[2] Natl & Kapodistrian Univ Athens, Dept Basic Med Sci, Lab Biol, Athens, Greece
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P408
引用
收藏
页码：S375 / S376
页数：2
相关论文
共 50 条
  • [11] Infliximab Dosing for Patients With Inflammatory Bowel Disease, Based on Trough Levels
    Lowe, Anson W.
    Moseley, Richard H.
    GASTROENTEROLOGY, 2015, 148 (07) : 1261 - 1261
  • [12] CLINICAL USE OF INFLIXIMAB TROUGH LEVELS DURING MAINTENANCE IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    van Hoeve, Karen
    Hoffman, Ilse
    Dreesen, Erwin
    Ferrante, Marc
    Ann, Gils
    Vermeire, Severine
    GASTROENTEROLOGY, 2018, 154 (06) : S1042 - S1042
  • [13] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Dreesen, E.
    Hoffman, I.
    Ferrante, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
  • [14] Infliximab trough levels for remission induction and long term therapy management of inflammatory bowel disease
    Perdigoto, D.
    Portela, F.
    Ferreira, M.
    Mendes, S.
    Freire, P.
    Ferreira, M.
    Lopes, S.
    Tome, L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S386 - S386
  • [15] Uncertain usefulness of infliximab trough levels for therapeutic decision-making in inflammatory bowel disease patients on infliximab maintenance therapy
    Canete, F.
    Lobaton, T.
    Cabre, E.
    Manosa, M.
    Teniente, A.
    Clos, A.
    Torres, P.
    Valldosera, G.
    Martinez-Caceres, E.
    Domenech, E.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S417 - S417
  • [16] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    Marzo, M.
    Felice, C.
    Mocci, G.
    De Vincentis, F.
    Andrisani, G.
    Pugliese, D.
    Fedeli, P.
    De Vitis, I.
    Papa, A.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S88 - S88
  • [17] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, Alessandro
    De pascalis, Barbara
    Roberto, Italia
    Ennas, Sara
    De vincentis, Fabio
    Guglielmo, Simona
    Fedeli, Paolo
    Papa, Alfredo
    De vitis, Italo
    Gasbarrini, Giovanni
    Melina, Domenico
    Fedeli, Giuseppe
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2007, 132 (04) : A183 - A183
  • [18] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S12 - S12
  • [19] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2009, 13 : 84 - 84
  • [20] Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease
    Armuzzi, Alessandro
    De Vincentis, Fabio
    Marzo, Manuela
    Mocci, Giammarco
    Felice, Carla
    Fedeli, Paolo
    De Vitis, Italo
    Papa, Alfredo
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2009, 136 (05) : A663 - A663
12345